IIQ 3.64% 53.0¢ inoviq ltd

Agree Hevlet - the most of us know the company is not great at...

  1. 38 Posts.
    lightbulb Created with Sketch. 9
    Agree Hevlet - the most of us know the company is not great at how they release announcements. With this being said it is nice to see progression with the clinical trial, and upon official results of the trial (if in line with the early 2021 SubB2M results we should surely see some share price appreciation.
 
watchlist Created with Sketch. Add IIQ (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.